Global Prefilled Formalin Vials Market Set to Surge, Projected to Reach US$ 515.8 Million by 2028

The global prefilled formalin vials market witnessed a remarkable upsurge, reaching approximately US$ 388.3 Million in 2021. According to recent market analysis, this trajectory is poised to continue, with a projected Compound Annual Growth Rate (CAGR) of 4.1%, ultimately soaring to a valuation of US$ 515.8 Million by 2028.

Formaldehyde, also recognized as methanol, is an organic compound, denoted by the formula CH2O (H-CHO). Prefilled formalin vials have emerged as a critical component in various industries, particularly in the manufacturing of methanol-based resins. Notably, urea-formaldehyde, urea-melamine-formaldehyde, and melamine-formaldehyde resins are extensively utilized across a spectrum of industrial applications.

Get your Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-7582

The burgeoning demand for prefilled formalin vials stems from its widespread utility in the medical domain, particularly in the realm of biopsies. These vials, sterilized and crafted from wide-mouth, clarified polypropylene containers, offer unparalleled convenience and clarity in visualizing samples within healthcare settings, including operating rooms, pathology labs, and medical facilities.

“Prefilled formalin vials are pivotal in histopathology, ensuring the preservation of biopsy tissue samples with utmost efficacy,” stated a FMI. “The increasing focus on bolstering the production of these vials to cater to the burgeoning demand from hospital pathology labs is poised to redefine the landscape of the global market in the foreseeable future.”

The market for prefilled formalin vials is anticipated to witness substantial growth, driven by the expanding application scope of the substance across various sectors. As industries continue to prioritize quality assurance and sample preservation, the demand for prefilled formalin vials is expected to remain robust, underlining its indispensable role in modern healthcare practices.

Key factor restraining the demand for prefilled formalin vials:

  • Occupational exposure: Formalin is a known irritant and carcinogen, posing a significant health risk to workers who handle it regularly.
  • Regulations: Organizations like the WHO and EU have established guidelines to limit occupational exposure to formalin.
  • Cancer risk: Studies suggest a link between prolonged or excessive formalin exposure and nasopharyngeal cancer.
  • Safety measures: To protect workers, minimizing formalin use and implementing safety protocols are crucial. This can lead to reduced demand for prefilled formalin vials.

In essence, the potential health hazards associated with formalin discourage its use, thereby impacting the market for prefilled formalin vials.

Get Customization on This Report: https://www.futuremarketinsights.com/customization-available/rep-gb-7582

Competitive Landscape:

The prefilled formalin vials market is fiercely contested by major competitors including Diapath S.p.A, Histo-Line Laboratories Srl, Cardinal Health, Inc., Leica Microsystems Sales GmbH (Leica Biosystems Nussloch GmbH), Genta Environmental Ltd., Carl Roth GmbH + Co. KG, Magnacol Ltd., Serosep Limited, Ultident Scientific, and Solmedia Limited.

To attract a wider customer base and enhance their product offerings, these key players are concentrating on expanding their market share in developed economies through partnerships with regional players and investment groups. Meanwhile, regional market players are prioritizing the establishment of long-term relationships with direct end-users to ensure a steady revenue stream.

  • In August 2021, Cardinal Health forged partnerships with Abbott and Quidel, broadening their product portfolio significantly.
  • In June 2021, Solmedia Limited entered into a partnership with German manufacturer SLEE medical GmbH, securing UK exclusivity for their premium range of high-precision pathological equipment.

Prefilled Formalin Vials Market by Category

By Product:

  • <10 mL
  • 10 – 20 mL
  • 20 – 40 mL
  • 40 – 60 mL
  • 60 – 90 mL
  • 90 – 500 mL
  • 500 mL – 1 lit.

By End User:

  • Hospitals
  • Clinics
  • Emergency Medical Services
  • Diagnostic Laboratories
  • Academic Institutes
  • Forensic Laboratories
  • Contract Research Organizations
  • Veterinary Clinics
  • Veterinary Laboratories
  • Veterinary Hospitals

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • MEA

Direct Purchase of this Report: https://www.futuremarketinsights.com/checkout/7582

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: 
sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Leave a comment

Your email address will not be published. Required fields are marked *